Cystine glutamate exchanger upregulation by retinoic acid induces neuroprotection in neural stem cells

NeuroReport

Volumn 22, Issue 12, 2011, Pages 598-602

  Crockett, Stephanie ^a   Clarke, Melinda ^b   Reeves, Shari ^b   Sims, Brian ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

glutathione biosynthesis; neural stem cells; retinoic acid; system Xc

Indexed keywords

CARRIER PROTEIN; CYSTINE; CYSTINE GLUTAMATE EXCHANGER; GLUTATHIONE; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; MOUSE; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; NEUROPROTECTIVE AGENTS; TRETINOIN; UP-REGULATION;

EID: 80051546375     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283494359     Document Type: Article

References (20)

1. Le Doze F, Debruyne D, Albessard F, Barre L, Defer GL. Pharmacokinetics of all-trans retinoic acid, 13-cis retinoic acid, and fenretinide in plasma and brain of rat. Drug Metab Dispos 2000; 28:205-208. (Pubitemid 30069005)
2. Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloidderived suppressor cells. Cancer Res 2007; 67:11021-11028. (Pubitemid 350145932)
3. Choi EJ,Whang YM, Kim SJ, Kim HJ, Kim YH. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro. J Korean Med Sci 2007; 20(Suppl):S52-S60.
4. Ahlemeyer B, Bauerbach E, Plath M, Steuber M, Heers C, Tegtmeier F, et al. Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med 2001; 30:1067-1077. (Pubitemid 32441831)
5. Defer GL, Adle-Biassette H, Ricolfi F, Martin L, Authier FJ, Chomienne C, et al. All-trans retinoic acid in relapsing malignant gliomas: Clinical and radiological stabilization associated with the appearance of intratumoral calcifications. J Neurooncol 1997; 34:169-177. (Pubitemid 27271723)
6. Takaki M, Ueda Y, Doi T, Nagatomo K, Murashima YL, Kannan H. Molecular regulation of antioxidant ability in the hippocampus of EL mice. Brain Res 2008; 1228:1-5.
7. La Bella V, Valentino F, Piccoli T, Piccoli F. Expression and developmental regulation of the cystine/glutamate exchanger (x (c) (-) ) in the rat. Neurochem Res 2007; 32:1081-1090. (Pubitemid 46726029)
8. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 2006; 26:10514-10523. (Pubitemid 44564602)
9. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50:553-562. (Pubitemid 33009976)
10. Chung WJ, Lyons SA, Nelson GM, et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 2005; 25:7101-7110. (Pubitemid 41113926)
11. Ahlemeyer B, Huhne R, Krieglstein J. Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J Neurosci Res 2000; 60:767-778. (Pubitemid 30399548)
12. Aoun P,Watson DG, Simpkins JW. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. Eur J Pharmacol 2003; 472:65-71. (Pubitemid 36833280)
13. Cao YJ, Shibata T, Rainov NG. Hypoxia-inducible transgene expression in differentiated human NT2N neurons: A cell culture model for gene therapy of postischemic neuronal loss. Gene Therapy 2001; 8:1357-1362. (Pubitemid 32834306)
14. Cheung YT, Lau WK, Yu MS, Lai CS, Yeung SC, So KF, et al. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 2009; 30:127-135.
15. Sims B, Clarke M, Njah W, Hopkins ES, Sontheimer H. Erythropoietininduced neuroprotection requires cystine glutamate exchanger activity. Brain Res 2010; 1321:88-95.
16. Bain G, Gottlieb DI. Neural cells derived by in vitro differentiation of P19 and embryonic stem cells. Perspect Dev Neurobiol 1998; 5:175-178. (Pubitemid 28505494)
17. Li L, Li Y, Ji X, Zhang B,Wei H, Luo Y. The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia. Brain Res 2008; 1226:234-240.
18. Mey J. New therapeutic target for CNS injury̌The role of retinoic acid signaling after nerve lesions. J Neurobiol 2006; 66:757-779. (Pubitemid 43939198)
19. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50:553-562. (Pubitemid 33009976)
20. Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. Mechanisms of oxidative glutamate toxicity: The glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Dr 2010; 9:373-382.